SEC Form 4 · accession 0001078782-16-003867
VOLITIONRX LTD · VNRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin Charles Faulkes
Director
Period of report
Nov 25, 2016
Accepted (ET)
Nov 28, 2016 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000093314
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 25, 2016 | M | 5,000 | $3.00 | A | 1,296,629 | D | |
| Common StockF1 | Nov 25, 2016 | F | 3,379 | $4.44 | D | 1,293,250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $3.00 | Nov 25, 2016 | M | 5,000 | D | Nov 25, 2012 | Nov 25, 2016 | Common Stock | 5,000 | 0 | D |
Explanation of responses
- F1Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction.